Western research effort evaporates while China reaches parity with the United States
Public research and development budgets fell by 5% in real terms in 2025 across OECD countries, marking the first widespread decline since the 2008 crisis. This contraction occurs at the precise moment when China reaches parity with the United States in total R&D spending, at approximately 1,050 billion dollars in purchasing power parity. While the West redirects its investments toward defense, Beijing maintains its trajectory of scientific expansion and is already seeing its universities attract researchers leaving America.
The shift is as sudden as it is symbolic. After decades of Western dominance in innovation, 2025 figures reveal a geographic redistribution of global research effort. The United States suffers the most severe decline with -7.9% in public funding, while its universities lose 20,000 researchers in one year. Europe follows suit with budget cuts that transform its laboratories into fiscal adjustment variables.
The essentials
- Public R&D budgets fall by 5% in 2025 across the OECD, with a 7.9% decline in the United States
- China reaches parity with America in total spending: 1,050 billion dollars in PPP each
- American universities lose 20,000 researchers in one year, mainly to Asia
- Western funding redeploys massively toward defense at the expense of fundamental research
- This reversal marks the end of 70 years of Western scientific hegemony
America Sacrifices Its Civilian Research on the Altar of Military Spending
American figures reveal a profound shift in national priorities. Of the 680 billion dollars in federal R&D spending in 2025, 62% now goes to defense compared to 48% in 2020. This reorientation has accelerated since the invasion of Ukraine and rising tensions with China, but it produces a major side effect: the collapse of civilian funding.
The National Institutes of Health see their budget stagnate at 47 billion dollars while medical inflation reaches 8% annually. The National Science Foundation loses 2.4 billion from its 2024 budget. These cuts directly affect universities that depend 65% on federal funding for their research programs. Stanford, MIT, and Caltech each announce the closure of entire laboratories due to lack of funds.
The human hemorrhage follows budgetary logic. The 20,000 researchers leaving American universities represent 12% of the workforce in hard sciences. They depart for Singapore, South Korea, and increasingly for mainland China. Tsinghua University opens six new research institutes led by former MIT professors. The reverse brain drain inverts the historical trend that saw America attracting global talent.
China Maintains Its Expansion Pace Despite Economic Slowdown
Beijing resists the temptation of budgetary retrenchment. Despite economic growth slowing to 4.2% in 2025, public R&D investments advance 8% in real terms. This strategic consistency brings China to financial parity with the United States for the first time in modern history.
China’s 1,050 billion dollars deploy according to a logic different from the American approach. Where Washington prioritizes immediate military applications, Beijing maintains balance between fundamental research and industrial development. The Chinese Academy of Sciences receives 180 billion dollars, four times the combined budget of the French CNRS and German Max Planck.
This strategy produces measurable results. China now publishes 23% of global scientific articles versus 18% for the United States, according to Scopus data. In artificial intelligence, its researchers sign 35% of reference publications. The country files 1.8 million patents annually, surpassing the United States, Europe, and Japan combined.
Expansion extends beyond volume. Chinese universities climb international rankings with a regularity that surprises observers. Tsinghua and Beijing now occupy the top 20 globally in science and engineering. Their programs attract 580,000 foreign students, primarily from Southeast Asia and Africa, creating tomorrow’s scientific networks.
Europe Chooses Scientific Austerity at the Worst Possible Time
The Old Continent amplifies American errors with catastrophic timing. Germany reduces the university research budget by 6% to finance rearmament. France freezes hiring at the CNRS despite 40% of research directors reaching retirement by 2030. The United Kingdom, outside the OECD but comparable, decreases Research UK credits by 12%.
These cuts occur while Europe already lagged structurally. Its total R&D spending represents 2.2% of GDP compared to 3.5% in the United States and 2.8% in China. The private investment deficit partially explains this gap: European companies devote 1.4% of their revenue to innovation versus 2.1% for American competitors.
The impact is measured in laboratories. The Max Planck Institute closes three quantum physics research centers. INSERM indefinitely postpones launching programs on gene therapies. British universities lose access to Horizon Europe since Brexit and see their research revenues drop 35%.
Paradoxically, this contraction coincides with the emergence of major scientific challenges that would require intensified mobilization. Climate change demands technological breakthroughs that only fundamental research can produce. Generative artificial intelligence transforms all sectors but remains poorly understood in its deep mechanisms. Future pandemics require R&D capacities that Covid revealed as insufficient in the West.
Geopolitical Consequences of Scientific Redistribution
This inversion of investments redraws the global map of innovation. For the first time since 1945, the West no longer concentrates the majority of planetary research effort. Asia now represents 47% of global spending compared to 32% for Europe and North America combined. This shift accelerates with relocations of industrial laboratories to Singapore, Taiwan, and South Korea.
The effect reverberates on technological development. Patents in artificial intelligence, biotechnologies, and renewable energies migrate toward Asia. China already dominates 70% of value chains in electric batteries and solar panels. It gains ground in pharmaceuticals with innovative molecules that European industry must now license.
Western universities lose their relative attractiveness. Asian students, who constituted 60% of foreign doctoral candidates in the United States, turn toward Chinese and Singaporean programs. This migration deprives the West of the talent pool that traditionally fed its scientific excellence.
The dynamic becomes self-reinforcing. Less public funding reduces the appeal of Western academic careers. The best researchers leave, weakening the quality of remaining programs. Technology companies follow competencies toward Asia, depriving universities of lucrative industrial partnerships.
Yet this redistribution is not irreversible. Switzerland maintains its R&D investment at 3.4% of GDP and preserves its position as a global leader in innovation according to the WIPO index. The Netherlands increase university budgets by 15% to attract European talent that their neighbors neglect. These examples prove that an ambitious scientific policy remains possible in the West.
The question becomes one of awakening. Will Western leaders understand that fundamental research constitutes a strategic investment, not discretionary spending? Or will they let China alone build the knowledge that will define the coming century? The answer lies in 2026 budgets, the last chance to reverse a trend that could become irreversible.